BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22465337)

  • 1. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts.
    Dijkman PE; Driessen-Mol A; Frese L; Hoerstrup SP; Baaijens FP
    Biomaterials; 2012 Jun; 33(18):4545-54. PubMed ID: 22465337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model.
    Weber B; Dijkman PE; Scherman J; Sanders B; Emmert MY; Grünenfelder J; Verbeek R; Bracher M; Black M; Franz T; Kortsmit J; Modregger P; Peter S; Stampanoni M; Robert J; Kehl D; van Doeselaar M; Schweiger M; Brokopp CE; Wälchli T; Falk V; Zilla P; Driessen-Mol A; Baaijens FP; Hoerstrup SP
    Biomaterials; 2013 Oct; 34(30):7269-80. PubMed ID: 23810254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
    Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
    Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
    Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
    J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
    Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
    J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-engineered larynx using perfusion-decellularized technique and mesenchymal stem cells in a rabbit model.
    Hou N; Cui P; Luo J; Ma R; Zhu L
    Acta Otolaryngol; 2011 Jun; 131(6):645-52. PubMed ID: 21332294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study.
    Hong H; Dong N; Shi J; Chen S; Guo C; Hu P; Qi H
    Artif Organs; 2009 Jul; 33(7):554-8. PubMed ID: 19566733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-dependent re-endothelialization of tissue-engineered heart valves.
    Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
    J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.